113 related articles for article (PubMed ID: 22486134)
1. Role of pentoxifylline in treatment of anemic patients suffering chronic hemodialysis: a randomized clinical trial.
Mortazavi M; Seyrafian S; Taheri S; Nasiri R; Dolatkhah S; Naini AE; Atapour A
Med Arh; 2012; 66(2):84-6. PubMed ID: 22486134
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.
Mohammadpour AH; Nazemian F; Khaiat MH; Tafaghodi M; Salari P; Charkazi S; Naghibi M; Shamsara J
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):73-8. PubMed ID: 24434385
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis.
Antunes SA; Vilela RQ; Vaz JD; Canziani ME
Int J Artif Organs; 2014 Jul; 37(7):521-8. PubMed ID: 25044383
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Bolignano D; D'Arrigo G; Pisano A; Coppolino G
PLoS One; 2015; 10(8):e0134104. PubMed ID: 26237421
[TBL] [Abstract][Full Text] [Related]
6. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P;
Nephrology (Carlton); 2017 Jul; 22(7):548-554. PubMed ID: 27171136
[TBL] [Abstract][Full Text] [Related]
7. Effect of Pentoxifylline on Inflammatory Cytokines, Adequacy of Dialysis, Anemia and Biochemical Markers of Hemodialysis Patients: a Randomized Controlled Trial.
Sedaghattalab M; Talebi V; Manzouri L; Larki RA; Doustimotlagh AH
Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073938
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
10. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
[TBL] [Abstract][Full Text] [Related]
11. [A study of anemia in 86 patients on hemodialysis (author's transl)].
Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
[TBL] [Abstract][Full Text] [Related]
12. Management of anemia with quotidian hemodialysis.
Rao M; Muirhead N; Klarenbach S; Moist L; Lindsay RM
Am J Kidney Dis; 2003 Jul; 42(1 Suppl):18-23. PubMed ID: 12830439
[TBL] [Abstract][Full Text] [Related]
13. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A
Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729
[TBL] [Abstract][Full Text] [Related]
14. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Clinical Trial of the Effect of Pentoxifylline on C-Reactive Protein Level and Dialysis Adequacy in End-stage Renal Disease Patients on Maintenance Hemodialysis.
Soltani P; Ketabi Moghaddam P; Haghverdi F; Cheraghi A
Iran J Kidney Dis; 2016 Sep; 10(5):299-303. PubMed ID: 27721228
[TBL] [Abstract][Full Text] [Related]
16. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
17. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
Tonelli M; Blake PG; Muirhead N
ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin requirements increase following hospitalization in end-stage renal disease patients.
Yaqub MS; Leiser J; Molitoris BA
Am J Nephrol; 2001; 21(5):390-6. PubMed ID: 11684801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
